PTEN and prostate carcinoma: In an earlier study, our group showed aggressive metastatic tumor growth in mice after deletion of signal transducer and activator of transcription 3 (STAT3) and phosphatase and tensin homolog (PTEN) in a murine transgenic mouse model for prostate cancer [16].